Sixteen researchers of Amsterdam UMC have been awarded a TKI-PPP grant between € 300.000 and € 750.000 to perform a research project in collaboration with an industrial party. The funding is provided by the NL government (Ministry of Economic Affairs) through the Rijksdienst voor Ondernemend Nederland (RVO) and the Topconsortium voor Kennis en Innovatie Life Sciences & Health (TKI-LSH, a.k.a. Health-Holland).
Examples of honored projects are the development of a novel nanovaccine that will result in a better treatment of cancer patients, longer survival and better quality of life, a machine learning technique that measures signals through EHG which will be able to predict premature labor based on historical cases and validation of a new treatment option for Alzheimer’s disease uniquely based on naturally occurring brain plasticity mechanisms.
In October 2019 the call for the Amsterdam UMC TKI grant 2020 opened. The Amsterdam UMC TKI grants for PPP projects are available to all Amsterdam UMC researchers who wish to perform a research project in collaboration with an industrial party. The grant is to stimulate Amsterdam UMC researchers to perform research projects together with companies in Public-Private Partnerships (PPP).
For the first time the TKI grant procedures from AMC and VUmc were combined. This also meant that the grant amounts available to both UMC’s were put together, creating a pot of approximately 9 million euros to be divided over our best PPP-research proposals.
During both selection rounds (pre- and final application), each proposal was judged by four jury members, consisting of two scientists selected from the eight Amsterdam UMC alliance institutes, an IXA business developer and an outside expert on impact (e.g. a life sciences venture capitalist).
Knowing that applying requires a serious effort of the researchers, we were very happy and proud to receive a total of 60 applications. The jury first selected 29 final proposals to go to the final round, after which the following 16 proposals could be awarded:
We wish all winning applicants lots of success performing their projects!
PULSE Sport, a start-up from the Demonstrator Lab, has reached a significant milestone by winning the prestigious 14th Dutch Sports Innovation Award. The company’s flagship product, a cutting-edge athlete management system, integrates advanced software and artificial intelligence to revolutionize athlete health and performance monitoring. About the Innovation PULSE Sport’s athlete management system provides a holistic […]
NewsVU-AMS is on a mission to revolutionize how we understand and manage stress-related health issues. Now an official VU spin-off, there are big plans for clinical applications. Founder of VU AMS Martin Gevonden explains: “We offer researchers autonomic biomarkers that are valid, reliable and easy to use, without getting under the skin.” After thriving in […]
NewsAmsterdam researchers have secured Biotech Booster funding for a total of six projects, that include a promising cancer treatment, a new diagnostic method for Alzheimer’s Disease, an implant helping blindness, lab innovation in biotechnology, and a nutritional intervention for mental health. The researchers will develop a solid business case for their innovations in the time […]
News